Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.5300 (-17.34%) ($6.0400 - $7.1900) on Fri. Aug. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.73% (three month average) | RSI | 58 | Latest Price | $6.5300(-17.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.9% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BND(93%) TLT(15%) EDOC(13%) CEMB(12%) GLD(12%) | Factors Impacting CAPR price | CAPR will decline at least -4.365% in a week (0% probabilities). XLB(-25%) PAVE(-22%) XOP(-21%) XLI(-21%) URA(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.365% (StdDev 8.73%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
Resistance Level | $6.98 | 5 Day Moving Average | $7.68(-14.97%) | 10 Day Moving Average | $8.2(-20.37%) | 20 Day Moving Average | $6.98(-6.45%) | To recent high | -33.4% | To recent low | 30.3% | Market Cap | $129m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |